dantrolene has been researched along with Neuroleptic Malignant Syndrome in 153 studies
Dantrolene: Skeletal muscle relaxant that acts by interfering with excitation-contraction coupling in the muscle fiber. It is used in spasticity and other neuromuscular abnormalities. Although the mechanism of action is probably not central, dantrolene is usually grouped with the central muscle relaxants.
dantrolene : The hydrazone resulting from the formal condensation of 5-(4-nitrophenyl)furfural with 1-aminohydantoin. A ryanodine receptor antagonist used for the relief of chronic severe spasticity and malignant hyperthermia.
Neuroleptic Malignant Syndrome: A potentially fatal syndrome associated primarily with the use of neuroleptic agents (see ANTIPSYCHOTIC AGENTS) which are in turn associated with dopaminergic receptor blockade (see RECEPTORS, DOPAMINE) in the BASAL GANGLIA and HYPOTHALAMUS, and sympathetic dysregulation. Clinical features include diffuse MUSCLE RIGIDITY; TREMOR; high FEVER; diaphoresis; labile blood pressure; cognitive dysfunction; and autonomic disturbances. Serum CPK level elevation and a leukocytosis may also be present. (From Adams et al., Principles of Neurology, 6th ed, p1199; Psychiatr Serv 1998 Sep;49(9):1163-72)
| Excerpt | Relevance | Reference |
|---|---|---|
| "After 9 years of treatment for Parkinson's disease, a 68-year-old woman developed the complications of neuroleptic malignant syndrome (NMS) and disseminated intravascular coagulation (DIC) while she was still receiving levodopa, bromocriptine and amantadine hydrochloride." | 8.78 | Successful treatment of levodopa-induced neuroleptic malignant syndrome (NMS) and disseminated intravascular coagulation (DIC) in a patient with Parkinson's disease. ( Ogawa, N; Yamawaki, Y, 1992) |
| "We present the case of a 42-year-old male with a history of schizophrenia who developed signs and symptoms consistent with Neuroleptic Malignant Syndrome (NMS) after 3 weeks of treatment with Olanzapine." | 7.70 | Neuroleptic malignant syndrome associated with olanzapine therapy: a case report. ( Privette, T; Stanfield, SC, 2000) |
| "The use of dantrolene sodium (DS) in the treatment of neuroleptic malignant syndrome (NMS) was studied from the data of 21 cases of NMS, which satisfied the diagnostic criteria of Pope et al." | 7.70 | The treatment of neuroleptic malignant syndrome using dantrolene sodium. ( Hata, S; Matsuura, S; Sakai, M; Shirakura, K; Tsutsumi, Y; Yamamoto, K, 1998) |
| " Experimental rabbits treated with haloperidol (1 mg/kg) by intramuscular injection, were studied for the diagnostic symptoms of increased muscle rigidity, elevated body temperature, and high serum creatine phosphokinase (CPK) level." | 7.69 | Development of an animal model for neuroleptic malignant syndrome: heat-exposed rabbits with haloperidol and atropine administration exhibit increased muscle activity, hyperthermia, and high serum creatine phosphokinase level. ( Hosono, T; Ikura, Y; Kudo, T; Niigawa, H; Nishimura, T; Sakamoto, S; Takeda, M; Taniguchi, N; Tanii, H, 1996) |
| "We report a case of fulminant neuroleptic malignant syndrome in a man aged 70 developing within 12 hours of starting six-hourly intravenous metoclopramide." | 7.68 | Fulminant metoclopramide induced neuroleptic malignant syndrome rapidly responsive to intravenous dantrolene. ( Henderson, A; Longdon, P, 1991) |
| " A diagnosis of neuroleptic malignant syndrome was made, and the patient was given dantrolene with prompt and complete resolution of all signs and symptoms." | 7.68 | Neuroleptic malignant syndrome induced by domperidone. ( Chan, W; Sachar, DB; Spirt, MJ; Thieberg, M, 1992) |
| "Homovanillic acid (HVA) and 5-hydroxyindoleacetic acid (5-HIAA) levels in the cerebrospinal fluid (CSF) were determined twice in nine cases of neuroleptic malignant syndrome (NMS) during the active phase." | 7.68 | Does dantrolene influence central dopamine and serotonin metabolism in the neuroleptic malignant syndrome? A retrospective study. ( Ishiguro, T; Nisijima, K, 1993) |
| "Clozapine is an atypical neuroleptic drug that was initially thought not to cause neuroleptic malignant syndrome (NMS)." | 7.68 | Neuroleptic malignant syndrome and clozapine. ( Minnema, AM; Reddig, S; Tandon, R, 1993) |
| "Patients with Parkinson's disease have been suspected to have a low incidence of DIC, and this may be the first case report on successful treatment of levodopa-induced NMS with DIC in the patient with Parkinson's disease." | 6.38 | [Successful treatment of levodopa-induced neuroleptic malignant syndrome (NMS) with disseminated intravascular coagulation (DIC) in a patient with Parkinson's disease]. ( Ogawa, N; Yamawaki, Y, 1991) |
| "Dantrolene has also been used successfully in the treatment of a few cases of heat stroke and the neuroleptic malignant syndrome--both of which have many similarities to malignant hyperthermia." | 6.37 | Dantrolene. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic use in malignant hyperthermia, the neuroleptic malignant syndrome and an update of its use in muscle spasticity. ( Chaffman, MO; Sorkin, EM; Ward, A, 1986) |
| "This article describes a patient with lethal catatonia: treatment by ECT alone was ineffective, whereas continued treatment with ECT in combination with dantrolene sodium led to improvement." | 5.28 | Treatment of lethal catatonia with electroconvulsive therapy and dantrolene sodium: a case report. ( Nolen, WA; Zwaan, WA, 1990) |
| "The authors report a case of neuroleptic malignant syndrome in a 78-year-old man." | 5.28 | Survival of severe neuroleptic malignant syndrome in a 78-year-old man treated with dantrolene. ( Kimerer, NB; Parker, DM; Sholer, CM; Trammell, JR, 1990) |
| "A case of neuroleptic malignant syndrome (NMS) with an abrupt onset was terminated quickly with i." | 5.27 | Resolution of neuroleptic malignant syndrome with dantrolene sodium: case report. ( Jaffe, JH; Khan, A; Morrison, B; Nelson, WH, 1985) |
| "A PubMed search was conducted through March 2016 using available medical subject heading (MeSH) terms and keywords that included neuroleptic malignant syndrome, treatment, dantrolene, and bromocriptine." | 4.93 | Neuroleptic Malignant Syndrome. ( Cook, AM; Pileggi, DJ, 2016) |
| "After 9 years of treatment for Parkinson's disease, a 68-year-old woman developed the complications of neuroleptic malignant syndrome (NMS) and disseminated intravascular coagulation (DIC) while she was still receiving levodopa, bromocriptine and amantadine hydrochloride." | 4.78 | Successful treatment of levodopa-induced neuroleptic malignant syndrome (NMS) and disseminated intravascular coagulation (DIC) in a patient with Parkinson's disease. ( Ogawa, N; Yamawaki, Y, 1992) |
| " Thus, dantrolene administration was initiated with a tentative diagnosis of neuroleptic malignant syndrome (NMS)." | 3.91 | Neuroleptic malignant syndrome as part of an akinetic crisis associated with sepsis in a patient with Lewy body disease. ( Manabe, S; Ozawa, H; Takagi, A; Yanagi, H, 2019) |
| " On suspicion of neuroleptic malignant syndrome(NMS) onset, dantrolene sodium hydrate was administered, resulting in marked improvement of the symptoms." | 3.80 | [Coronary artery spasm induced by neuroleptic malignant syndrome during off-pump coronary artery bypass grafting; report of a case]. ( Mori, A; Nitta, Y; Yamaya, K; Yoshida, S, 2014) |
| " Following initial improvement, she developed delayed rhabdomyolysis then haloperidol-induced neuroleptic malignant syndrome, which was treated with a total of 50 mg." | 3.78 | Ecstacy-induced delayed rhabdomyolysis and neuroleptic malignant syndrome in a patient with a novel variant in the ryanodine receptor type 1 gene. ( Hawryluck, LA; Kraeva, N; Riazi, S; Russell, T; Steel, AC, 2012) |
| " Eight days later, he presented with a neuroleptic malignant syndrome following an injection of droperidol." | 3.70 | Malignant hyperthermia and neuroleptic malignant syndrome in a patient during treatment for acute asthma. ( Cardinaud, JP; Favier, JC; Gbikpi-Benissan, G; Gruson, D; Hilbert, G; Portel, L, 1999) |
| "We present the case of a 42-year-old male with a history of schizophrenia who developed signs and symptoms consistent with Neuroleptic Malignant Syndrome (NMS) after 3 weeks of treatment with Olanzapine." | 3.70 | Neuroleptic malignant syndrome associated with olanzapine therapy: a case report. ( Privette, T; Stanfield, SC, 2000) |
| " Experimental rabbits treated with haloperidol (1 mg/kg) by intramuscular injection, were studied for the diagnostic symptoms of increased muscle rigidity, elevated body temperature, and high serum creatine phosphokinase (CPK) level." | 3.69 | Development of an animal model for neuroleptic malignant syndrome: heat-exposed rabbits with haloperidol and atropine administration exhibit increased muscle activity, hyperthermia, and high serum creatine phosphokinase level. ( Hosono, T; Ikura, Y; Kudo, T; Niigawa, H; Nishimura, T; Sakamoto, S; Takeda, M; Taniguchi, N; Tanii, H, 1996) |
| " We report a case of this rare syndrome in a head injury patient associated with some unusual features: rhabdomyolysis with a high level of creatine kinase, the development of acute renal failure, the early use of continuous venovenous haemofiltration in treatment and rigidity that was refractory to conventional treatment with dantrolene and bromocriptine." | 3.69 | Neuroleptic malignant syndrome in a patient with head injury. ( Alted Lopez, E; Ambros Checa, A; Caballero Cubedo, R; Perez-Vela, JL; Sanchez Casado, M; Sanchez-Izquierdo Riera, JA, 1996) |
| " A diagnosis of neuroleptic malignant syndrome was made, and the patient was given dantrolene with prompt and complete resolution of all signs and symptoms." | 3.68 | Neuroleptic malignant syndrome induced by domperidone. ( Chan, W; Sachar, DB; Spirt, MJ; Thieberg, M, 1992) |
| "We report the lst case of neuroleptic malignant syndrome occurring in a patient receiving desipramine, a tricyclic antidepressant, with no exposure to neuroleptics." | 3.68 | Neuroleptic malignant syndrome: a unique association with a tricyclic antidepressant. ( Baca, L; Martinelli, L, 1990) |
| "We performed a case-controlled analysis on the effectiveness of dantrolene and certain dopamine agonists--bromocriptine, amantadine 3,4-dihydroxyphenylalanine, (DOPA)--for the neuroleptic malignant syndrome (NMS)." | 3.68 | Drug treatment of the neuroleptic malignant syndrome. ( Davis, JM; Janicak, PG; Sakkas, P; Wang, ZY, 1991) |
| "Homovanillic acid (HVA) and 5-hydroxyindoleacetic acid (5-HIAA) levels in the cerebrospinal fluid (CSF) were determined twice in nine cases of neuroleptic malignant syndrome (NMS) during the active phase." | 3.68 | Does dantrolene influence central dopamine and serotonin metabolism in the neuroleptic malignant syndrome? A retrospective study. ( Ishiguro, T; Nisijima, K, 1993) |
| "Clozapine is an atypical neuroleptic drug that was initially thought not to cause neuroleptic malignant syndrome (NMS)." | 3.68 | Neuroleptic malignant syndrome and clozapine. ( Minnema, AM; Reddig, S; Tandon, R, 1993) |
| "We present the case of a 35-year-old man who developed symptoms of the neuroleptic malignant syndrome (NMS) after taking prescribed, moderately high, therapeutic doses of haloperidol." | 3.67 | Neuroleptic malignant syndrome. ( Lucid, EJ; Martin, ML; Walker, RW, 1985) |
| "Eleven patients with various cancer types from ten case reports published from 1988 to 2013 met the eligibility criteria." | 2.66 | Neuroleptic malignant syndrome in patients with cancer: a systematic review. ( Ishida, M; Kawakami, K; Kawanishi, C; Onishi, H; Sato, I; Yamada, S, 2020) |
| "Malignant hyperthermia is a hypermetabolic syndrome that appears in susceptible patients after exposure to certain anaesthetic drugs (succinylcholine, inhalation anaesthetics)." | 2.55 | Clinical protocol for the management of malignant hyperthermia. ( Alsina, E; Del Blanco, B; Domínguez, A; García, A; Guerrero, JL; Kollmann-Camaiora, A; Yepes, MJ, 2017) |
| "Serotonin syndrome (SS) and neuroleptic malignant syndrome (NMS) are uncommon but potentially life-threatening adverse reactions associated with psychotropic medications." | 2.48 | Serotonin syndrome vs neuroleptic malignant syndrome: a contrast of causes, diagnoses, and management. ( Perry, PJ; Wilborn, CA, 2012) |
| "Human malignant hyperthermia is a life-threatening genetic sensitivity of skeletal muscles to volatile anaesthetics and depolarizing neuromuscular blocking drugs occurring during or after anaesthesia." | 2.42 | Dantrolene--a review of its pharmacology, therapeutic use and new developments. ( Fiege, M; Gerbershagen, MU; Krause, T; Wappler, F; Weisshorn, R, 2004) |
| "Dantrolene is a skeletal muscle relaxant that depresses the excitation-contraction coupling,however, the specificity of action remains unknown." | 2.42 | [Dantrolene. Pharmacological and therapeutic aspects]. ( Agarwal, K; Fiege, M; Gerbershagen, MU; Krause, T; Wappler, F, 2003) |
| "The neuroleptic malignant syndrome is a rare, potentially fatal, adverse reaction to neuroleptic drugs characterised by severe rigidity, high temperature and autonomic dysfunction." | 2.40 | The neuroleptic malignant syndrome: a logical approach to the patient with temperature and rigidity. ( Balzan, MV, 1998) |
| " switching to a low-potency or an atypical antipsychotic, lowering the dosage or discontinuing the NL, and adding a drug effective in treating EPS." | 2.40 | Algorithms for the treatment of acute side effects induced by neuroleptics. ( Koyama, T; Kusumi, I, 1999) |
| "Neuroleptic malignant syndrome is a rare complication of antipsychotic medications." | 2.39 | Neuroleptic malignant syndrome in a trauma patient. ( Burke, C; Castellano, J; Fulda, GJ, 1995) |
| "Neuroleptic malignant syndrome and malignant hyperthermia share two cardinal clinical features: hypothermia and rigidity." | 2.38 | Neuroleptic malignant syndrome and malignant hyperthermia. Important issues for the medical consultant. ( Heiman-Patterson, TD, 1993) |
| "This is a review article on neuroleptic malignant syndrome." | 2.38 | [Neuroleptic malignant syndrome]. ( Retamal, P, 1990) |
| "Patients with Parkinson's disease have been suspected to have a low incidence of DIC, and this may be the first case report on successful treatment of levodopa-induced NMS with DIC in the patient with Parkinson's disease." | 2.38 | [Successful treatment of levodopa-induced neuroleptic malignant syndrome (NMS) with disseminated intravascular coagulation (DIC) in a patient with Parkinson's disease]. ( Ogawa, N; Yamawaki, Y, 1991) |
| "Neuroleptic malignant syndrome is a rare but potentially fatal reaction associated with neuroleptic drugs." | 2.38 | Neuroleptic malignant syndrome. ( Caroff, SN; Mann, SC, 1993) |
| "Neuroleptic malignant syndrome is a rare but serious adverse effect of antipsychotic medication." | 2.37 | Neuroleptic malignant syndrome. ( Levenson, JL, 1985) |
| "New publications on malignant hyperthermia (MH), with direct clinical importance, are reported." | 2.37 | [New findings and experiences in the field of malignant hyperthermia]. ( Eberlein, HJ; Schulte-Sasse, U, 1986) |
| "Dantrolene has also been used successfully in the treatment of a few cases of heat stroke and the neuroleptic malignant syndrome--both of which have many similarities to malignant hyperthermia." | 2.37 | Dantrolene. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic use in malignant hyperthermia, the neuroleptic malignant syndrome and an update of its use in muscle spasticity. ( Chaffman, MO; Sorkin, EM; Ward, A, 1986) |
| "BACKGROUND Considering the ongoing coronavirus disease 2019 (COVID-19) pandemic, sufficient information about common and serious adverse events is needed to rapidly distribute COVID-19 vaccines worldwide." | 1.72 | Neuroleptic Malignant Syndrome with Adrenal Insufficiency After BNT162b2 COVID-19 Vaccination in a Man Taking Valproate: A Case Report. ( Kamiyama, T; Mizuno, T; Suzuki, A; Suzuki, M; Takahashi, R, 2022) |
| "She was diagnosed with neuroleptic malignant syndrome (NMS) induced by the discontinuation of psychotropic drugs." | 1.72 | [A case of neuroleptic malignant syndrome caused by discontinuation of psychotropic drugs]. ( Suzuki, M; Takahashi, Y; Togashi, A; Yaguchi, H; Yaguchi, M, 2022) |
| "Neuroleptic malignant syndrome is a neurological emergency caused by dysregulation of dopaminergic neurotransmission." | 1.62 | Diagnosis and Treatment of Neuroleptic Malignant Syndrome in the Intensive Care Unit: A Case Report. ( Barahona-Corrêa, B; Cotovio, G; Maia, A; Oliveira-Maia, AJ, 2021) |
| " Quetiapine-induced NMS has occurred with long-term use in the elderly in the outpatient setting." | 1.56 | Neuroleptic Malignant Syndrome Secondary to Quetiapine in Critical Care: A Case Report. ( Dwyer, R; Nestor, C; O'Brien, D, 2020) |
| "Acute dystonia is also a well-known and more common adverse effect of certain types of antipsychotics, more commonly seen with the typical antipsychotics versus the atypical antipsychotics." | 1.46 | Acute Dystonia Versus Neuroleptic Malignant Syndrome Without Fever in an Eight-Year-Old Child. ( Nesbit, CE; Sridaran, R, 2017) |
| " NMS occurs most often during the first week of treatment or after increasing the dosage of the neuroleptic medication." | 1.43 | [Case report: Neuroleptic malignant syndrome and diagnostic difficulties]. ( Khouri, C; Logerot, S; Mallaret, M; Planès, S; Villier, C, 2016) |
| "Serotonin syndrome (SS) and neuroleptic malignant syndrome (NMS) are life-threatening adverse reactions caused by serotonergic antidepressants and neuroleptics, respectively." | 1.42 | Serotonin syndrome overlapping with neuroleptic malignant syndrome: A case report and approaches for differentially diagnosing the two syndromes. ( Nisijima, K, 2015) |
| "An 80-year-old woman with Parkinson's disease was scheduled for open heart surgery to repair thoracic aortic aneurysm." | 1.39 | [Case of neuroleptic malignant syndrome following open heart surgery for thoracic aortic aneurysm with parkinson's disease]. ( Ando, Y; Sakamoto, M; Shindo, Y; Shinoda, M; Tateda, T, 2013) |
| "Dantrolene was administered in a dose of 60 mg per day and he recovered consciousness and his CK level began to decrease." | 1.39 | [Neuroleptic malignant syndrome after cardiac surgery]. ( Fuzii, A; Higami, T; Inaoka, M; Miyaki, Y; Nakashima, S; Uehara, M, 2013) |
| "Under a diagnosis of neuroleptic malignant syndrome, dantrolene was administered." | 1.38 | [Comatose patient with neuroleptic malignant syndrome brought by ambulance]. ( Kuroda, Y; Takinami, Y, 2012) |
| "We report a case of severe neuroleptic malignant syndrome developing in a 28-year-old female patient following deliberate self-poisoning with atypical antipsychotic drugs and serotonin reuptake inhibitors." | 1.36 | [Intensive care treatment for neuroleptic malignant syndrome]. ( Binder, C; Böhler, K; Hensel, M; Marnitz, R; von Brevern, M, 2010) |
| "The diagnosis was kept as neuroleptic malignant syndrome after ruling out other possibilities." | 1.35 | Electroconvulsive therapy in drug resistant neuroleptic malignant syndrome. ( Joshi, AS; Khobragade, AK; Patel, AL; Sahastrabuddhe, GS; Shaikh, WA; Soni, HG, 2008) |
| "Catatonia was first described by Kahlbaum in 1874." | 1.34 | Catatonia and neuroleptic malignant syndrome: two sides of a coin? ( Santens, P; Vancaester, E, 2007) |
| "Hyponatremia in patients with neuroleptic malignant syndrome might more likely reflect cerebral salt-wasting syndrome than a syndrome of inappropriate secretion of antidiuretic hormone as an additional aspect of autonomic dysregulation caused by antidopaminergic drugs." | 1.34 | Cerebral salt-wasting syndrome in a patient with neuroleptic malignant syndrome. ( Külkens, S; Lenhard, T; Schwab, S, 2007) |
| "Neuroleptic malignant syndrome is a rare but potentially lethal, rare reaction to neuroleptics which is characterized by altered levels of consciousness, extrapyramidal effects, autonomic instability, hyperthermia, and elevated serum creatine phosphokinase levels." | 1.33 | Successful treatment of six patients with neuroleptic malignant syndrome associated with myoglobulinemic acute renal failure. ( Higashi, H; Hirakata, H; Hirano, T; Iida, M; Matsui, R; Sanai, T; Torichigai, S; Yotsueda, H, 2006) |
| "The incidence of neuroleptic malignant syndrome (NMS) is not known, but the frequency of its occurrence with conventional antipsychotic agents has been reported to vary from 0." | 1.32 | Neuroleptic malignant syndrome and atypical antipsychotic drugs. ( Ananth, J; Burgoyne, K; Gunatilake, S; Parameswaran, S; Sidhom, T, 2004) |
| "In the patients with Parkinson's disease, it is sometimes provoked by discontinuation of anti-Parkinsonism agents." | 1.32 | A case of malignant syndrome associated with a parkinsonism patient. ( Nomura, S; Sanga, M, 2003) |
| "We report an unusual case of neuroleptic malignant syndrome that presented predominantly with autonomic instability in the form of recurrent episodes of respiratory distress." | 1.31 | Neuroleptic malignant syndrome presenting as pulmonary edema and severe bronchorrhea. ( Agrawal, M; Krishnan, P; Niranjan, S; Patel, U, 2002) |
| "Patients with Parkinson's disease associated with NMS are considered to have a low incidence of DIC, status epilepticus, and in Japan this may be the first case report of the successful treatment of NMS with DIC and status epilepticus in a patient with Parkinson's disease." | 1.30 | [A successfully treated parkinsonian patient with neuroleptic malignant syndrome complicated by status epilepticus and disseminated intravascular coagulation]. ( Miyoshi, T; Motomura, S; Osoegawa, M; Tamura, K; Yamanaka, H, 1999) |
| "Dantrolene sodium iv was administered for three days." | 1.29 | Neuroleptic malignant-like syndrome: a complication of acute organophosphate poisoning. ( Arai, T; Hatakenaka, S; Ochi, G; Tokuoka, H; Watanabe, K, 1995) |
| "Pneumonia and renal failure significantly increased the morbidity and extended the course of the illness." | 1.29 | An atypical course of neuroleptic malignant syndrome. ( Marken, PA; Schneiderhan, ME, 1994) |
| "Treatment with dantrolene sodium combined with a forced alkaline diuresis resulted in a full recovery." | 1.29 | Postoperative neuroleptic malignant syndrome. ( Matthews, EE; Shaw, A, 1995) |
| "One of these complications is the acute renal failure." | 1.29 | [Acute renal failure in neuroleptic malignant syndrome]. ( Rónai, L; Wagner, G, 1995) |
| "Neuroleptic malignant syndrome is a potentially fatal syndrome that can occur in patients taking neuroleptics or other psychotropic drugs." | 1.29 | Neuroleptic malignant syndrome: a dangerous complication of neuroleptic therapy. ( Byrd, C, 1993) |
| "Rhabdomyolysis is a clinical disorder arising from skeletal muscle injury." | 1.29 | The neuroleptic malignant syndrome and acute renal failure. ( Becker, BN; Ismail, N, 1994) |
| "This article describes a patient with lethal catatonia: treatment by ECT alone was ineffective, whereas continued treatment with ECT in combination with dantrolene sodium led to improvement." | 1.28 | Treatment of lethal catatonia with electroconvulsive therapy and dantrolene sodium: a case report. ( Nolen, WA; Zwaan, WA, 1990) |
| "The natural course of untreated neuroleptic malignant syndrome (NMS) does not usually exceed 3 weeks." | 1.28 | [Protracted recurrent neuroleptic malignant syndrome]. ( Delerue, O; Destée, A, 1990) |
| "A case of postoperative neuroleptic malignant syndrome is presented." | 1.27 | Postoperative neuroleptic malignant syndrome. A case report. ( Bristow, G; Patel, P, 1987) |
| "A case of neuroleptic malignant syndrome (NMS) with an abrupt onset was terminated quickly with i." | 1.27 | Resolution of neuroleptic malignant syndrome with dantrolene sodium: case report. ( Jaffe, JH; Khan, A; Morrison, B; Nelson, WH, 1985) |
| "A patient who developed neuroleptic malignant syndrome (NMS) from the use of several neuroleptic agents and the therapeutic interventions used to reverse the syndrome are described, and the clinical presentation and treatment of NMS are reviewed." | 1.27 | Diagnosis and treatment of neuroleptic malignant syndrome. ( Guerrero, RM; Shifrar, KA, 1988) |
| "Malignant Hyperthermia is a specific potentially fatal condition which occurs in susceptible individuals in response to various triggering mechanisms, of which anesthetic agents have been found to be the most common offenders." | 1.27 | [Malignant neuroleptic syndrome and malignant hyperthermia--a comparison]. ( Hippius, H; Spiess-Kiefer, C, 1986) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 38 (24.84) | 18.7374 |
| 1990's | 59 (38.56) | 18.2507 |
| 2000's | 31 (20.26) | 29.6817 |
| 2010's | 18 (11.76) | 24.3611 |
| 2020's | 7 (4.58) | 2.80 |
| Authors | Studies |
|---|---|
| Mizuno, T | 1 |
| Takahashi, R | 2 |
| Kamiyama, T | 1 |
| Suzuki, A | 1 |
| Suzuki, M | 2 |
| Takahashi, Y | 1 |
| Yaguchi, M | 1 |
| Yaguchi, H | 1 |
| Togashi, A | 1 |
| Sato, I | 1 |
| Onishi, H | 1 |
| Kawanishi, C | 2 |
| Yamada, S | 1 |
| Ishida, M | 1 |
| Kawakami, K | 1 |
| Kajani, R | 1 |
| Apramian, A | 1 |
| Vega, A | 1 |
| Ubhayakar, N | 1 |
| Xu, P | 1 |
| Liu, A | 1 |
| Kuhlwilm, L | 1 |
| Schönfeldt-Lecuona, C | 1 |
| Gahr, M | 1 |
| Connemann, BJ | 1 |
| Keller, F | 1 |
| Sartorius, A | 1 |
| Nestor, C | 1 |
| O'Brien, D | 1 |
| Dwyer, R | 1 |
| Maia, A | 1 |
| Cotovio, G | 1 |
| Barahona-Corrêa, B | 1 |
| Oliveira-Maia, AJ | 1 |
| Wystub, N | 1 |
| Heymel, S | 1 |
| Fritzenwanger, M | 1 |
| Schulze, PC | 1 |
| Pfeifer, R | 1 |
| Whyte, CJ | 1 |
| Rosini, JM | 1 |
| Manabe, S | 1 |
| Yanagi, H | 1 |
| Ozawa, H | 1 |
| Takagi, A | 1 |
| Uehara, M | 1 |
| Inaoka, M | 1 |
| Miyaki, Y | 1 |
| Nakashima, S | 1 |
| Fuzii, A | 1 |
| Higami, T | 1 |
| Shinoda, M | 1 |
| Sakamoto, M | 1 |
| Shindo, Y | 1 |
| Ando, Y | 1 |
| Tateda, T | 1 |
| Mori, A | 1 |
| Yamaya, K | 1 |
| Nitta, Y | 1 |
| Yoshida, S | 1 |
| Kouparanis, A | 1 |
| Bozikas, A | 1 |
| Spilioti, M | 1 |
| Tziomalos, K | 1 |
| Nisijima, K | 4 |
| Khouri, C | 1 |
| Planès, S | 1 |
| Logerot, S | 1 |
| Villier, C | 1 |
| Mallaret, M | 1 |
| Kameda, K | 1 |
| Watarai, K | 1 |
| Takahashi, K | 1 |
| Shoko, T | 1 |
| Koinuma, M | 1 |
| Ikushima, G | 1 |
| Pileggi, DJ | 1 |
| Cook, AM | 1 |
| Kollmann-Camaiora, A | 1 |
| Alsina, E | 1 |
| Domínguez, A | 1 |
| Del Blanco, B | 1 |
| Yepes, MJ | 1 |
| Guerrero, JL | 1 |
| García, A | 1 |
| Sridaran, R | 1 |
| Nesbit, CE | 1 |
| Hensel, M | 1 |
| Böhler, K | 1 |
| Marnitz, R | 1 |
| Binder, C | 1 |
| von Brevern, M | 1 |
| Rosenberg, H | 1 |
| Rueffert, H | 1 |
| Takinami, Y | 1 |
| Kuroda, Y | 1 |
| Perry, PJ | 1 |
| Wilborn, CA | 1 |
| Russell, T | 1 |
| Riazi, S | 1 |
| Kraeva, N | 1 |
| Steel, AC | 1 |
| Hawryluck, LA | 1 |
| Lappa, A | 1 |
| Podestà, M | 1 |
| Capelli, O | 1 |
| Castagna, A | 1 |
| Di Placido, G | 1 |
| Alampi, D | 1 |
| Semeraro, F | 1 |
| Reingardiene, D | 1 |
| Gerbershagen, MU | 3 |
| Fiege, M | 3 |
| Krause, T | 2 |
| Agarwal, K | 1 |
| Wappler, F | 3 |
| Sanga, M | 2 |
| Nomura, S | 2 |
| Nishijima, K | 1 |
| Mieno, S | 1 |
| Asada, K | 1 |
| Horimoto, H | 1 |
| Sasaki, S | 1 |
| Weisshorn, R | 1 |
| Ananth, J | 1 |
| Parameswaran, S | 1 |
| Gunatilake, S | 1 |
| Burgoyne, K | 1 |
| Sidhom, T | 1 |
| Nicholson, D | 1 |
| Chiu, W | 1 |
| Ferioli, V | 1 |
| Manes, A | 1 |
| Melloni, C | 1 |
| Nanni, S | 1 |
| Boncompagni, G | 1 |
| Gaig, C | 1 |
| Martí, MJ | 1 |
| Tolosa, E | 1 |
| Gómez-Choco, MJ | 1 |
| Amaro, S | 1 |
| Ward, C | 1 |
| Nagamine, M | 1 |
| Yoshino, A | 1 |
| Sakurai, Y | 1 |
| Sanai, T | 1 |
| Matsui, R | 1 |
| Hirano, T | 1 |
| Torichigai, S | 1 |
| Yotsueda, H | 1 |
| Higashi, H | 1 |
| Hirakata, H | 1 |
| Iida, M | 1 |
| Strawn, JR | 2 |
| Keck, PE | 2 |
| Smidt, MH | 1 |
| Collumbien, EC | 1 |
| Lenhard, T | 1 |
| Külkens, S | 1 |
| Schwab, S | 1 |
| Reulbach, U | 1 |
| Dütsch, C | 1 |
| Biermann, T | 1 |
| Sperling, W | 1 |
| Thuerauf, N | 1 |
| Kornhuber, J | 3 |
| Bleich, S | 1 |
| Tsuchiya, N | 1 |
| Morimura, E | 1 |
| Hanafusa, T | 1 |
| Shinomura, T | 1 |
| Roberts, DM | 1 |
| Roberts, JA | 1 |
| Caroff, SN | 3 |
| Brvar, M | 1 |
| Bunc, M | 1 |
| Vancaester, E | 1 |
| Santens, P | 1 |
| Jitsuiki, H | 1 |
| Yamashita, H | 1 |
| Kozuru, T | 1 |
| Yamawaki, S | 2 |
| Furuno, T | 1 |
| Kishida, I | 1 |
| Patel, AL | 1 |
| Shaikh, WA | 1 |
| Khobragade, AK | 1 |
| Soni, HG | 1 |
| Joshi, AS | 1 |
| Sahastrabuddhe, GS | 1 |
| Bismuth, C | 1 |
| de Rohan-Chabot, P | 1 |
| Goulon, M | 1 |
| Raphael, JC | 1 |
| Konikoff, F | 1 |
| Kuritzky, A | 1 |
| Jerushalmi, Y | 1 |
| Theodor, E | 1 |
| Ellis, FR | 1 |
| Gómez, EA | 1 |
| Burke, C | 1 |
| Fulda, GJ | 1 |
| Castellano, J | 1 |
| Wagner, G | 1 |
| Rónai, L | 1 |
| Ishiguro, T | 3 |
| Shaw, A | 1 |
| Matthews, EE | 1 |
| Bello, N | 1 |
| Adnet, P | 1 |
| Saulnier, F | 1 |
| Lestavel, P | 1 |
| Adnet-Bonte, C | 1 |
| Reyford, H | 1 |
| Etchrivi, T | 1 |
| Tavernier, B | 1 |
| Krivosic-Horber, R | 1 |
| Matoba, M | 1 |
| Weller, M | 2 |
| Schneiderhan, ME | 1 |
| Marken, PA | 1 |
| Mann, SC | 1 |
| Heiman-Patterson, TD | 1 |
| Kurien, T | 1 |
| Rajeev, KK | 1 |
| Abraham, OC | 1 |
| Archana, S | 1 |
| Cherian, AM | 1 |
| Reddig, S | 1 |
| Minnema, AM | 1 |
| Tandon, R | 1 |
| Cape, G | 1 |
| Becker, BN | 1 |
| Ismail, N | 1 |
| Stemp, LI | 1 |
| Byrd, C | 1 |
| Velamoor, VR | 2 |
| Swamy, GN | 1 |
| Parmar, RS | 1 |
| Williamson, P | 1 |
| Ochi, G | 1 |
| Watanabe, K | 1 |
| Tokuoka, H | 1 |
| Hatakenaka, S | 1 |
| Arai, T | 1 |
| Perez-Vela, JL | 1 |
| Sanchez Casado, M | 1 |
| Sanchez-Izquierdo Riera, JA | 1 |
| Ambros Checa, A | 1 |
| Caballero Cubedo, R | 1 |
| Alted Lopez, E | 1 |
| Real Rodríguez, B | 1 |
| Ruibal, JL | 1 |
| Grande Rodríguez, S | 1 |
| Sueiro Pita, B | 1 |
| Tanii, H | 1 |
| Taniguchi, N | 1 |
| Niigawa, H | 1 |
| Hosono, T | 1 |
| Ikura, Y | 1 |
| Sakamoto, S | 1 |
| Kudo, T | 1 |
| Nishimura, T | 1 |
| Takeda, M | 1 |
| Noguti, M | 1 |
| Naito, Y | 1 |
| Balzan, MV | 1 |
| Tsutsumi, Y | 1 |
| Yamamoto, K | 1 |
| Matsuura, S | 1 |
| Hata, S | 1 |
| Sakai, M | 1 |
| Shirakura, K | 1 |
| Still, J | 1 |
| Friedman, B | 1 |
| Law, E | 1 |
| Deppe, S | 1 |
| Epperly, N | 1 |
| Orlet, H | 1 |
| Portel, L | 1 |
| Hilbert, G | 1 |
| Gruson, D | 1 |
| Favier, JC | 1 |
| Gbikpi-Benissan, G | 1 |
| Cardinaud, JP | 1 |
| Gönner, F | 1 |
| Baumgartner, R | 1 |
| Schüpbach, D | 1 |
| Merlo, MC | 1 |
| Osoegawa, M | 1 |
| Motomura, S | 1 |
| Yamanaka, H | 1 |
| Tamura, K | 1 |
| Miyoshi, T | 1 |
| Loynes, J | 1 |
| Tann, S | 1 |
| Redick, D | 1 |
| Hickman, R | 1 |
| Trasmonte, J | 1 |
| Dayner, J | 1 |
| Barron, TF | 1 |
| Kusumi, I | 1 |
| Koyama, T | 1 |
| Stanfield, SC | 1 |
| Privette, T | 1 |
| Fink, M | 1 |
| Yeolekar, ME | 1 |
| Gupta, H | 1 |
| Ito, WD | 1 |
| Schulte am Esch, J | 1 |
| Patel, U | 1 |
| Agrawal, M | 1 |
| Krishnan, P | 1 |
| Niranjan, S | 1 |
| Yamawaki, Y | 2 |
| Ogawa, N | 2 |
| Chiang, WK | 1 |
| Herschman, Z | 1 |
| Spirt, MJ | 1 |
| Chan, W | 1 |
| Thieberg, M | 1 |
| Sachar, DB | 1 |
| Hetherington, N | 1 |
| Larner, AJ | 1 |
| Shader, RI | 1 |
| Greenblatt, DJ | 1 |
| Pennati, A | 1 |
| Sacchetti, E | 1 |
| Calzeroni, A | 1 |
| Miller, DD | 1 |
| Sharafuddin, MJ | 1 |
| Kathol, RG | 1 |
| Sczesni, B | 2 |
| Becker, H | 1 |
| Schröder, J | 1 |
| Bittkau, S | 1 |
| von Baumgarten, F | 1 |
| Truong, DD | 2 |
| Przuntek, H | 1 |
| Sakkas, P | 1 |
| Davis, JM | 1 |
| Janicak, PG | 1 |
| Wang, ZY | 1 |
| Retamal, P | 1 |
| Henderson, A | 1 |
| Longdon, P | 1 |
| Rosebush, PI | 1 |
| Stewart, T | 1 |
| Mazurek, MF | 1 |
| Rechlin, T | 1 |
| Hilz, MJ | 1 |
| Claus, D | 1 |
| Hard, C | 1 |
| Van de Kelft, E | 1 |
| De Hert, M | 1 |
| Heytens, L | 1 |
| Demey, HE | 1 |
| Gheuens, J | 1 |
| Epperly, TD | 1 |
| McGlaughlin, VG | 1 |
| Leo, KU | 1 |
| Usandizaga, I | 1 |
| Pérez de Mendiola, MM | 1 |
| Buades, J | 1 |
| Martínez, J | 1 |
| Baca, L | 1 |
| Martinelli, L | 1 |
| Delerue, O | 1 |
| Destée, A | 1 |
| Haisma, HJ | 1 |
| Constantinou, E | 1 |
| Chinyanga, HM | 1 |
| Kimerer, NB | 1 |
| Parker, DM | 1 |
| Sholer, CM | 1 |
| Trammell, JR | 1 |
| Hallberg, A | 1 |
| Björk, E | 1 |
| Martinussen, HJ | 1 |
| Trost, AC | 1 |
| Nolen, WA | 1 |
| Zwaan, WA | 1 |
| Spiess-Kiefer, C | 1 |
| Hippius, H | 1 |
| García Castaño, J | 1 |
| García Roman, M | 1 |
| Pinilla Llorente, B | 1 |
| Gilsanz Fernández, C | 1 |
| Shalev, A | 2 |
| Hermesh, H | 1 |
| Munitz, H | 2 |
| López, JR | 1 |
| López, MJ | 1 |
| Sánchez, V | 1 |
| Lazarus, A | 2 |
| Sewell, DD | 1 |
| Jeste, DV | 1 |
| Denborough, M | 1 |
| Fricchione, GL | 1 |
| Levenson, JL | 1 |
| Gibb, WR | 1 |
| Lees, AJ | 1 |
| Knight, ME | 1 |
| Roberts, RJ | 1 |
| Greenberg, MS | 1 |
| Gorelick, PB | 1 |
| Wergowske, GL | 1 |
| Carmody, TJ | 1 |
| Fahn, S | 1 |
| Gross, J | 1 |
| Donovan, K | 1 |
| van Bakel, A | 1 |
| Wiley, MK | 1 |
| Olmsted, TR | 1 |
| Schulte-Sasse, U | 2 |
| Eberlein, HJ | 2 |
| Pariante, F | 1 |
| Caddeo, S | 1 |
| Idone, F | 1 |
| Schettini, C | 1 |
| Guerrero, RM | 1 |
| Shifrar, KA | 1 |
| Yamawaki, N | 1 |
| Andrade, NN | 1 |
| Abbott, RJ | 1 |
| Loizou, LA | 1 |
| Ward, A | 1 |
| Chaffman, MO | 1 |
| Sorkin, EM | 1 |
| Patel, P | 1 |
| Bristow, G | 1 |
| Lesser, MS | 1 |
| Kahan, M | 1 |
| Brenner, R | 1 |
| Nayak, D | 1 |
| Yanagawa, K | 1 |
| Morio, M | 1 |
| Mori, K | 1 |
| Guzé, BH | 1 |
| Baxter, LR | 1 |
| Khan, A | 1 |
| Jaffe, JH | 1 |
| Nelson, WH | 1 |
| Morrison, B | 1 |
| Rosse, R | 1 |
| Ciolino, C | 1 |
| Komar, K | 1 |
| Martin, ML | 1 |
| Lucid, EJ | 1 |
| Walker, RW | 1 |
| Renfordt, E | 1 |
| Wardin, B | 1 |
39 reviews available for dantrolene and Neuroleptic Malignant Syndrome
| Article | Year |
|---|---|
Neuroleptic malignant syndrome in patients with cancer: a systematic review.
Topics: Adult; Aged; Aged, 80 and over; Antipsychotic Agents; Dantrolene; Dopamine D2 Receptor Antagonists; | 2020 |
The neuroleptic malignant syndrome-a systematic case series analysis focusing on therapy regimes and outcome.
Topics: Antipsychotic Agents; Dantrolene; Electroconvulsive Therapy; Humans; Neuroleptic Malignant Syndrome | 2020 |
Neuroleptic Malignant Syndrome.
Topics: Antipsychotic Agents; Dantrolene; Diagnosis, Differential; Humans; Mental Disorders; Neuroleptic Mal | 2016 |
Clinical protocol for the management of malignant hyperthermia.
Topics: Adolescent; Adult; Caffeine; Calcium Signaling; Child; Child, Preschool; Clinical Protocols; Critica | 2017 |
Serotonin syndrome vs neuroleptic malignant syndrome: a contrast of causes, diagnoses, and management.
Topics: Antipsychotic Agents; Dantrolene; Diagnosis, Differential; Humans; Muscle Relaxants, Central; Neurol | 2012 |
[Neuroleptic malignant syndrome].
Topics: Acute Kidney Injury; Adult; Amantadine; Bromocriptine; Carbidopa; Contraindications; Dantrolene; Dia | 2002 |
[Dantrolene. Pharmacological and therapeutic aspects].
Topics: Dantrolene; Drug Interactions; Hallucinogens; Humans; Malignant Hyperthermia; Muscle Relaxants, Cent | 2003 |
[Neuroleptic malignant syndrome].
Topics: Antipsychotic Agents; Bromocriptine; Dantrolene; Diagnosis, Differential; Diazepam; Dopamine D2 Rece | 2003 |
Dantrolene--a review of its pharmacology, therapeutic use and new developments.
Topics: Dantrolene; Humans; Malignant Hyperthermia; Muscle Relaxants, Central; Neuroleptic Malignant Syndrom | 2004 |
Neuroleptic malignant syndrome.
Topics: Aged; Dantrolene; Diagnosis, Differential; Diagnostic and Statistical Manual of Mental Disorders; Do | 2004 |
Managing an effective treatment for neuroleptic malignant syndrome.
Topics: Adult; Antipsychotic Agents; Dantrolene; Drug Therapy, Combination; Female; Humans; Logistic Models; | 2007 |
Neuroleptic malignant syndrome.
Topics: Adult; Amantadine; Antiparkinson Agents; Antipsychotic Agents; Benzodiazepines; Bromocriptine; Dantr | 2007 |
[Drug-induced neuroleptic malignant syndrome].
Topics: Antiparkinson Agents; Antipsychotic Agents; Autonomic Nervous System Diseases; Dantrolene; Diagnosis | 2007 |
[Drug-induced neuroleptic malignant syndrome].
Topics: Biomarkers; Bromocriptine; Creatine Kinase, MM Form; Cytochrome P-450 CYP2D6; Dantrolene; Diagnosis, | 2007 |
Neuroleptic malignant syndrome in a trauma patient.
Topics: Adult; Antipsychotic Agents; Dantrolene; Droperidol; Haloperidol; Humans; Male; Multiple Trauma; Mus | 1995 |
Neuroleptic malignant syndrome.
Topics: Dantrolene; Diagnosis, Differential; Dopamine Agents; Excitatory Amino Acids; Humans; Neuroleptic Ma | 1994 |
Neuroleptic malignant syndrome.
Topics: Age Factors; Antipsychotic Agents; Dantrolene; Diagnosis, Differential; Dopamine Agents; Electric St | 1993 |
Neuroleptic malignant syndrome and malignant hyperthermia. Important issues for the medical consultant.
Topics: Dantrolene; Diagnosis, Differential; Dopamine Agents; Humans; Malignant Hyperthermia; Neuroleptic Ma | 1993 |
Management of suspected neuroleptic malignant syndrome.
Topics: Adult; Antipsychotic Agents; Combined Modality Therapy; Dantrolene; Dopamine Agonists; Electroconvul | 1995 |
[The neuroleptic malignant syndrome in an adolescent. Its treatment with dantrolene, bromocryptin and diazepam].
Topics: Adolescent; Anti-Anxiety Agents; Antidepressive Agents, Tricyclic; Antiparkinson Agents; Antipsychot | 1996 |
[Neuroleptic malignant syndrome-dopamine-serotonin syndrome--the physiopathology, diagnosis, and therapy].
Topics: Animals; Appetite Depressants; Dantrolene; Dopamine D2 Receptor Antagonists; Fenfluramine; Humans; M | 1997 |
The neuroleptic malignant syndrome: a logical approach to the patient with temperature and rigidity.
Topics: Critical Care; Dantrolene; Dopamine Agonists; Fever; Humans; Muscle Relaxants, Central; Neuroleptic | 1998 |
Algorithms for the treatment of acute side effects induced by neuroleptics.
Topics: Algorithms; Antiparkinson Agents; Antipsychotic Agents; Basal Ganglia Diseases; Bromocriptine; Dantr | 1999 |
Successful treatment of levodopa-induced neuroleptic malignant syndrome (NMS) and disseminated intravascular coagulation (DIC) in a patient with Parkinson's disease.
Topics: Aged; Antithrombins; Benzamidines; Dantrolene; Disseminated Intravascular Coagulation; Female; Guani | 1992 |
[Pathophysiology and therapy of malignant neuroleptic syndrome].
Topics: Amantadine; Antipsychotic Agents; Dantrolene; Dopamine; Dopamine Agents; Drug Therapy, Combination; | 1992 |
[Neuroleptic malignant syndrome].
Topics: Antipsychotic Agents; Bromocriptine; Dantrolene; Diagnosis, Differential; Humans; Neuroleptic Malign | 1990 |
[Successful treatment of levodopa-induced neuroleptic malignant syndrome (NMS) with disseminated intravascular coagulation (DIC) in a patient with Parkinson's disease].
Topics: Aged; Benzamidines; Dantrolene; Disseminated Intravascular Coagulation; Female; Guanidines; Humans; | 1991 |
Mortality from neuroleptic malignant syndrome.
Topics: Adolescent; Adult; Aged; Child; Child, Preschool; Dantrolene; Dopamine Agents; Female; Haloperidol; | 1989 |
Neuroleptic malignant syndrome.
Topics: Amantadine; Brain; Bromocriptine; Dantrolene; Humans; Neuroleptic Malignant Syndrome; Prognosis | 1989 |
Neuroleptic malignant syndrome: a review.
Topics: Bromocriptine; Dantrolene; Diagnosis, Differential; Heat Exhaustion; Humans; Neuroleptic Malignant S | 1989 |
Neuroleptic malignant syndrome.
Topics: Adolescent; Adult; Aged; Antipsychotic Agents; Basal Ganglia Diseases; Bromocriptine; Child; Dantrol | 1985 |
The neuroleptic malignant syndrome--a review.
Topics: Animals; Antipsychotic Agents; Catatonia; Dantrolene; Diagnosis, Differential; Heat Exhaustion; Huma | 1985 |
Phenothiazine and butyrophenone intoxication in children.
Topics: Absorption; Adolescent; Basal Ganglia Diseases; Benztropine; Butyrophenones; Cardiovascular System; | 1986 |
The neuroleptic malignant syndrome: agent and host interaction.
Topics: Adolescent; Adult; Aftercare; Aged; Akathisia, Drug-Induced; Amantadine; Antiparkinson Agents; Antip | 1986 |
Neuroleptic malignant syndrome.
Topics: Antipsychotic Agents; Dantrolene; Dopamine; Humans; Malignant Hyperthermia; Neuroleptic Malignant Sy | 1987 |
[New findings and experiences in the field of malignant hyperthermia].
Topics: Anesthesia; Animals; Calcium Channel Blockers; Catatonia; Dantrolene; Diagnosis, Differential; Human | 1986 |
Neuroleptic malignant syndrome.
Topics: Adult; Amantadine; Animals; Body Temperature; Bromocriptine; Dantrolene; Diagnosis, Differential; Fe | 1986 |
Dantrolene. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic use in malignant hyperthermia, the neuroleptic malignant syndrome and an update of its use in muscle spasticity.
Topics: Animals; Calcium; Central Nervous System; Dantrolene; Endocrine Glands; Heat Exhaustion; Humans; Kin | 1986 |
Current concepts. Neuroleptic malignant syndrome.
Topics: Amantadine; Basal Ganglia Diseases; Bromocriptine; Catatonia; Dantrolene; Diagnosis, Differential; D | 1985 |
114 other studies available for dantrolene and Neuroleptic Malignant Syndrome
| Article | Year |
|---|---|
Neuroleptic Malignant Syndrome with Adrenal Insufficiency After BNT162b2 COVID-19 Vaccination in a Man Taking Valproate: A Case Report.
Topics: Adrenal Insufficiency; Adrenocorticotropic Hormone; BNT162 Vaccine; Bromocriptine; COVID-19; Dantrol | 2022 |
[A case of neuroleptic malignant syndrome caused by discontinuation of psychotropic drugs].
Topics: Aged; Antipsychotic Agents; Dantrolene; Female; Humans; Neuroleptic Malignant Syndrome; Psychotropic | 2022 |
Neuroleptic malignant syndrome in a COVID-19 patient.
Topics: Acute Kidney Injury; Antipsychotic Agents; Betacoronavirus; Bromocriptine; C-Reactive Protein; Coron | 2020 |
Neuroleptic Malignant Syndrome Secondary to Quetiapine in Critical Care: A Case Report.
Topics: Aged; Antipsychotic Agents; Critical Care; Dantrolene; Humans; Neuroleptic Malignant Syndrome; Queti | 2020 |
Diagnosis and Treatment of Neuroleptic Malignant Syndrome in the Intensive Care Unit: A Case Report.
Topics: Aged; Benzodiazepines; Dantrolene; Fever; Humans; Intensive Care Units; Male; Neuroleptic Malignant | 2021 |
[Prolonged neuroleptic malignant syndrome after Haloperidol injection].
Topics: Antipsychotic Agents; Dantrolene; Haloperidol; Humans; Male; Middle Aged; Neuroleptic Malignant Synd | 2018 |
Dantrolene for Treatment of Suspected Neuroleptic Malignant Syndrome.
Topics: Analgesics, Opioid; Anticonvulsants; Antipsychotic Agents; Benzodiazepines; Dantrolene; Diagnosis, D | 2018 |
Neuroleptic malignant syndrome as part of an akinetic crisis associated with sepsis in a patient with Lewy body disease.
Topics: Aged; Anti-Bacterial Agents; Dantrolene; Diagnosis, Differential; Female; Fluid Therapy; Humans; Lew | 2019 |
[Neuroleptic malignant syndrome after cardiac surgery].
Topics: Aortic Valve; Buprenorphine; Dantrolene; Diazepam; Endocarditis; Flunitrazepam; Humans; Male; Middle | 2013 |
[Case of neuroleptic malignant syndrome following open heart surgery for thoracic aortic aneurysm with parkinson's disease].
Topics: Aged, 80 and over; Anesthesia; Aortic Aneurysm, Thoracic; Cardiac Surgical Procedures; Dantrolene; E | 2013 |
[Coronary artery spasm induced by neuroleptic malignant syndrome during off-pump coronary artery bypass grafting; report of a case].
Topics: Coronary Artery Bypass, Off-Pump; Coronary Vasospasm; Dantrolene; Female; Humans; Middle Aged; Muscl | 2014 |
Neuroleptic malignant syndrome in a patient on long-term olanzapine treatment at a stable dose: Successful treatment with dantrolene.
Topics: Aged, 80 and over; Benzodiazepines; Dantrolene; Female; Humans; Neuroleptic Malignant Syndrome; Olan | 2015 |
Serotonin syndrome overlapping with neuroleptic malignant syndrome: A case report and approaches for differentially diagnosing the two syndromes.
Topics: Antidepressive Agents, Tricyclic; Clinical Decision-Making; Cyproheptadine; Dantrolene; Depressive D | 2015 |
[Case report: Neuroleptic malignant syndrome and diagnostic difficulties].
Topics: Antipsychotic Agents; Dantrolene; Female; Humans; Intellectual Disability; Middle Aged; Muscle Relax | 2016 |
Pharmaceutical Approach for the Diagnosis and Treatment of Malignant Syndrome: A Case Study.
Topics: Administration, Oral; Adult; Antipsychotic Agents; Bromocriptine; Dantrolene; Drug Therapy, Combinat | 2016 |
Acute Dystonia Versus Neuroleptic Malignant Syndrome Without Fever in an Eight-Year-Old Child.
Topics: Antipsychotic Agents; Aripiprazole; Child; Dantrolene; Dystonia; Emergency Service, Hospital; Humans | 2017 |
[Intensive care treatment for neuroleptic malignant syndrome].
Topics: Adult; Antidepressive Agents; Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Coma; Creatin | 2010 |
Clinical utility gene card for: malignant hyperthermia.
Topics: Age Factors; Biopsy; Calcium Channels; Calcium Channels, L-Type; Dantrolene; Diagnosis, Differential | 2011 |
[Comatose patient with neuroleptic malignant syndrome brought by ambulance].
Topics: Adult; Ambulances; Basal Ganglia Diseases; Chlorpromazine; Coma; Dantrolene; Drug Overdose; Female; | 2012 |
Ecstacy-induced delayed rhabdomyolysis and neuroleptic malignant syndrome in a patient with a novel variant in the ryanodine receptor type 1 gene.
Topics: Anesthetics, Inhalation; Antipsychotic Agents; Body Temperature; Caffeine; Central Nervous System St | 2012 |
Successful treatment of a complicated case of neuroleptic malignant syndrome.
Topics: Administration, Oral; Adult; Antipsychotic Agents; Dantrolene; Disseminated Intravascular Coagulatio | 2002 |
A case of malignant syndrome associated with a parkinsonism patient.
Topics: Antiparkinson Agents; Dantrolene; Fluid Therapy; Humans; Male; Middle Aged; Muscle Relaxants, Centra | 2003 |
Neuroleptic malignant syndrome following cardiac surgery: successful treatment with dantrolene.
Topics: Dantrolene; Heart Septal Defects, Atrial; Humans; Male; Middle Aged; Muscle Relaxants, Central; Neur | 2003 |
Neuroleptic malignant syndrome and atypical antipsychotic drugs.
Topics: Adult; Aged; Antipsychotic Agents; Benzodiazepines; Bromocriptine; Clozapine; Dantrolene; Dibenzothi | 2004 |
Atypical neuroleptic malignant syndrome caused by clozapine and venlafaxine: early brief treatment with dantrolene.
Topics: Adult; Clozapine; Cyclohexanols; Dantrolene; GABA Antagonists; Humans; Male; Muscle Relaxants, Centr | 2004 |
Parkinsonism-hyperpyrexia syndrome not related to antiparkinsonian treatment withdrawal during the 2003 summer heat wave.
Topics: Aged; Antiparkinson Agents; Bromocriptine; Dantrolene; Diagnosis, Differential; Female; Fever of Unk | 2005 |
Neuroleptic malignant syndrome in a patient with Parkinson's disease: a case study.
Topics: Aged; Antiparkinson Agents; Confusion; Dantrolene; Deep Brain Stimulation; Dehydration; Dopamine Age | 2005 |
Exacerbating factors in neuroleptic malignant syndrome: comparisons between cases with death, sequelae, and full recovery.
Topics: Aged; Antipsychotic Agents; Body Temperature; Bromocriptine; Cause of Death; Creatine Kinase; Dantro | 2005 |
Successful treatment of six patients with neuroleptic malignant syndrome associated with myoglobulinemic acute renal failure.
Topics: Acute Kidney Injury; Adult; Dantrolene; Female; Humans; Male; Middle Aged; Neuroleptic Malignant Syn | 2006 |
Early bicarbonate loading and dantroline for ziprasidone/haloperidol-induced neuroleptic malignant syndrome.
Topics: Adolescent; Antipsychotic Agents; Autistic Disorder; Combined Modality Therapy; Dantrolene; Disrupti | 2006 |
[A cocaine-induced variant of the neuroleptic malignant syndrome. A case study].
Topics: Bromocriptine; Cocaine; Dantrolene; Dopamine Agonists; Humans; Male; Middle Aged; Muscle Relaxants, | 2006 |
Cerebral salt-wasting syndrome in a patient with neuroleptic malignant syndrome.
Topics: Creatine Kinase; Dantrolene; Female; Humans; Hyponatremia; Inappropriate ADH Syndrome; Middle Aged; | 2007 |
Postoperative neuroleptic malignant syndrome that occurred repeatedly in a patient with cerebral palsy.
Topics: Anesthesia, General; Antipsychotic Agents; Body Temperature; Cerebral Palsy; Child; Creatine Kinase; | 2007 |
Conclusions regarding the efficacy of treatments for neuroleptic malignant syndrome should be tempered given poor quality data, regardless of the analysis conducted.
Topics: Dantrolene; Humans; Muscle Relaxants, Central; Neuroleptic Malignant Syndrome; Research Design; Trea | 2007 |
Video of dantrolene effectiveness on neuroleptic malignant syndrome associated muscular rigidity and tremor.
Topics: Aged; Dantrolene; Humans; Muscle Relaxants, Central; Muscle Rigidity; Neuroleptic Malignant Syndrome | 2007 |
Catatonia and neuroleptic malignant syndrome: two sides of a coin?
Topics: Adult; Aged; Alcoholism; Anticonvulsants; Antipsychotic Agents; Bipolar Disorder; Brain Injuries; Br | 2007 |
Electroconvulsive therapy in drug resistant neuroleptic malignant syndrome.
Topics: Adult; Bromocriptine; Dantrolene; Dopamine Agonists; Electroconvulsive Therapy; Female; Humans; Musc | 2008 |
Dantrolene--a new therapeutic approach to the neuroleptic malignant syndrome.
Topics: Adolescent; Adult; Basal Ganglia Diseases; Dantrolene; Haloperidol; Heat Exhaustion; Humans; Hyperte | 1984 |
Neuroleptic malignant syndrome induced by a single injection of haloperidol.
Topics: Basal Ganglia Diseases; Dantrolene; Female; Haloperidol; Humans; Middle Aged; Neuroleptic Malignant | 1984 |
Malignant hyperpyrexia.
Topics: Adult; Anesthesia, General; Animals; Calcium; Child; Dantrolene; Heat Exhaustion; Humans; Malignant | 1984 |
[Extrapyramidal reactions and neuroleptic malignant syndrome].
Topics: Adult; Amantadine; Basal Ganglia Diseases; Dantrolene; Haloperidol; Humans; Male; Neuroleptic Malign | 1984 |
[Acute renal failure in neuroleptic malignant syndrome].
Topics: Acute Kidney Injury; Adult; Antipsychotic Agents; Bromocriptine; Dantrolene; Humans; Male; Muscle Re | 1995 |
Does dantrolene influence central dopamine and serotonin metabolism in the neuroleptic malignant syndrome? A retrospective study.
Topics: Adult; Dantrolene; Dopamine; Female; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Male; Midd | 1993 |
Postoperative neuroleptic malignant syndrome.
Topics: Child; Dantrolene; Diuresis; Droperidol; Female; Humans; Hyponatremia; Metoclopramide; Neuroleptic M | 1995 |
[Lack of sensitivity to per-anesthetic malignant hyperthermia in 32 patients who developed neuroleptic malignant syndrome].
Topics: Adolescent; Adult; Aged; Anesthesia, General; Caffeine; Contracture; Creatine Kinase; Dantrolene; Di | 1994 |
Single photon emission computed tomography with 123I-IMP in three cases of the neuroleptic malignant syndrome.
Topics: Adult; Amphetamines; Antipsychotic Agents; Basal Ganglia; Brain; Dantrolene; Dose-Response Relations | 1994 |
An atypical course of neuroleptic malignant syndrome.
Topics: Amantadine; Bromocriptine; Dantrolene; Drug Therapy, Combination; Emergency Service, Hospital; Human | 1994 |
Management of neuroleptic malignant syndrome--a series of eight cases.
Topics: Adolescent; Adult; Bromocriptine; Carbidopa; Dantrolene; Dopamine Agents; Drug Combinations; Female; | 1993 |
Neuroleptic malignant syndrome and clozapine.
Topics: Adult; Antipsychotic Agents; Bromocriptine; Clozapine; Dantrolene; Diagnosis, Differential; Fever; H | 1993 |
Neuroleptic malignant syndrome--a cautionary tale and a surprising outcome.
Topics: Activities of Daily Living; Adaptation, Psychological; Adult; Antisocial Personality Disorder; Combi | 1994 |
The neuroleptic malignant syndrome and acute renal failure.
Topics: Acute Kidney Injury; Bromocriptine; Dantrolene; Diagnosis, Differential; Female; Fever; Humans; Midd | 1994 |
Management of lethal catatonia with dantrolene sodium.
Topics: Catatonia; Dantrolene; Electroconvulsive Therapy; Humans; Malignant Hyperthermia; Neuroleptic Malign | 1993 |
Neuroleptic malignant syndrome: a dangerous complication of neuroleptic therapy.
Topics: Adult; Bromocriptine; Dantrolene; Diagnosis, Differential; Humans; Male; Neuroleptic Malignant Syndr | 1993 |
Neuroleptic malignant-like syndrome: a complication of acute organophosphate poisoning.
Topics: Atropine; Cholinesterase Reactivators; Cholinesterases; Dantrolene; Female; Humans; Middle Aged; Mio | 1995 |
Neuroleptic malignant syndrome in a patient with head injury.
Topics: Adolescent; Bromocriptine; Craniocerebral Trauma; Creatine Kinase; Dantrolene; Hemofiltration; Human | 1996 |
Development of an animal model for neuroleptic malignant syndrome: heat-exposed rabbits with haloperidol and atropine administration exhibit increased muscle activity, hyperthermia, and high serum creatine phosphokinase level.
Topics: Animals; Antipsychotic Agents; Atropine; Body Temperature Regulation; Cholinergic Antagonists; Creat | 1996 |
Intravenous injection of levodopa is more effective than dantrolene as therapy for neuroleptic malignant syndrome.
Topics: Adult; Dantrolene; Dopamine Agents; Female; Humans; Injections, Intravenous; Levodopa; Male; Muscle | 1997 |
The treatment of neuroleptic malignant syndrome using dantrolene sodium.
Topics: Adolescent; Adult; Aged; Consciousness; Dantrolene; Female; Humans; Male; Middle Aged; Neuroleptic M | 1998 |
Neuroleptic malignant syndrome in a burn patient.
Topics: Accidents, Occupational; Adult; Antipsychotic Agents; Bromocriptine; Burns; Dantrolene; Debridement; | 1998 |
Malignant hyperthermia and neuroleptic malignant syndrome in a patient during treatment for acute asthma.
Topics: Acute Disease; Adjuvants, Anesthesia; Adult; Anesthetics, Inhalation; Asthma; Bronchodilator Agents; | 1999 |
Neuroleptic malignant syndrome during low dosed neuroleptic medication in first-episode psychosis: a case report.
Topics: Adult; Antipsychotic Agents; Clozapine; Dantrolene; Female; Fluphenazine; Humans; Muscle Relaxants, | 1999 |
[A successfully treated parkinsonian patient with neuroleptic malignant syndrome complicated by status epilepticus and disseminated intravascular coagulation].
Topics: Anticoagulants; Antiparkinson Agents; Bromocriptine; Dantrolene; Disseminated Intravascular Coagulat | 1999 |
Neuroleptic malignant syndrome.
Topics: Adult; Dantrolene; Female; Humans; Muscle Relaxants, Central; Neuroleptic Malignant Syndrome; Risk F | 1999 |
Neuroleptic malignant syndrome in an adolescent head trauma patient.
Topics: Accidents, Traffic; Adolescent; Age Factors; Anti-Dyskinesia Agents; Bromocriptine; Craniocerebral T | 1999 |
Neuroleptic malignant syndrome associated with olanzapine therapy: a case report.
Topics: Adult; Anti-Bacterial Agents; Antipsychotic Agents; Benzodiazepines; Bromocriptine; Combined Modalit | 2000 |
Treating neuroleptic malignant syndrome as catatonia.
Topics: Catatonia; Dantrolene; Dopamine Agonists; Humans; Muscle Relaxants, Central; Neuroleptic Malignant S | 2001 |
Persistent fever in a case of typhoid--an unusual cause of neuroleptic malignant syndrome.
Topics: Adult; Dantrolene; Diagnosis, Differential; Humans; Male; Muscle Relaxants, Central; Neuroleptic Mal | 2001 |
[Malignant neuroleptic syndrome after haloperidol administration].
Topics: Aged; Antipsychotic Agents; Catecholamines; Critical Care; Dantrolene; Depressive Disorder; Haloperi | 2001 |
Neuroleptic malignant syndrome presenting as pulmonary edema and severe bronchorrhea.
Topics: Amantadine; Antipsychotic Agents; Bromocriptine; Dantrolene; Dopamine Agonists; Dopamine Antagonists | 2002 |
Lethal catatonia and neuroleptic malignant syndrome.
Topics: Bromocriptine; Catatonia; Dantrolene; Diagnosis, Differential; Humans; Neuroleptic Malignant Syndrom | 1992 |
Neuroleptic malignant syndrome induced by domperidone.
Topics: Dantrolene; Diabetes Mellitus, Type 1; Domperidone; Female; Humans; Malignant Hyperthermia; Middle A | 1992 |
Dantrolene.
Topics: Dantrolene; Drug Interactions; Humans; Malignant Hyperthermia; Neuroleptic Malignant Syndrome; Spasm | 1992 |
Neuroleptic malignant syndrome.
Topics: Biomarkers; Dantrolene; Female; Humans; In Vitro Techniques; Male; Malignant Hyperthermia; Muscle Ri | 1992 |
A possible new approach to the treatment of neuroleptic malignant syndrome.
Topics: Animals; Dantrolene; Disease Models, Animal; Humans; Neuroleptic Malignant Syndrome | 1992 |
Dantrolene in lethal catatonia.
Topics: Antipsychotic Agents; Bipolar Disorder; Catatonia; Dantrolene; Female; Humans; Middle Aged; Neurolep | 1991 |
A case of clozapine-induced neuroleptic malignant syndrome.
Topics: Antipsychotic Agents; Clozapine; Dantrolene; Humans; Male; Middle Aged; Neuroleptic Malignant Syndro | 1991 |
[Diagnostic and therapeutic aspects of neuroleptic malignant syndrome based on 12 cases].
Topics: Adult; Amantadine; Antipsychotic Agents; Bromocriptine; Dantrolene; Depressive Disorder; Diazepam; D | 1991 |
Drug treatment of the neuroleptic malignant syndrome.
Topics: Amantadine; Bromocriptine; Dantrolene; Dihydroxyphenylalanine; Dopamine Agents; Humans; Neuroleptic | 1991 |
Fulminant metoclopramide induced neuroleptic malignant syndrome rapidly responsive to intravenous dantrolene.
Topics: Aged; Dantrolene; Humans; Infusions, Intravenous; Male; Metoclopramide; Neuroleptic Malignant Syndro | 1991 |
The treatment of neuroleptic malignant syndrome. Are dantrolene and bromocriptine useful adjuncts to supportive care?
Topics: Adult; Bromocriptine; Combined Modality Therapy; Critical Care; Dantrolene; Female; Humans; Male; Mi | 1991 |
[Successful treatment of the neuroleptic malignant syndrome using i.v. dantrolene sodium in the neurologic intensive care station].
Topics: Adult; Critical Care; Dantrolene; Humans; Injections, Intravenous; Male; Middle Aged; Neuroleptic Ma | 1991 |
Neuroleptic malignant syndrome versus malignant hyperthermia.
Topics: Dantrolene; Diagnosis, Differential; Humans; Malignant Hyperthermia; Neuroleptic Malignant Syndrome | 1991 |
Management of lethal catatonia with dantrolene sodium.
Topics: Adult; Catatonia; Dantrolene; Diagnosis, Differential; Humans; Male; Neuroleptic Malignant Syndrome | 1991 |
A hazardous side effect of neuroleptics: diagnosis and treatment.
Topics: Antipsychotic Agents; Bromocriptine; Dantrolene; Diagnosis, Differential; Female; Humans; Middle Age | 1990 |
[Neuroleptic malignant syndrome].
Topics: Adult; Biperiden; Chlormethiazole; Chlorpromazine; Dantrolene; Diazepam; Female; Haloperidol; Humans | 1990 |
Neuroleptic malignant syndrome: a unique association with a tricyclic antidepressant.
Topics: Bromocriptine; Dantrolene; Desipramine; Dopamine; Drug Therapy, Combination; Female; Humans; Middle | 1990 |
[Protracted recurrent neuroleptic malignant syndrome].
Topics: Adult; Bromocriptine; Dantrolene; Dose-Response Relationship, Drug; Female; Haloperidol; Humans; Neu | 1990 |
Neuroleptic malignant syndrome.
Topics: Adult; Bromocriptine; Chlorpromazine; Dantrolene; Female; Haloperidol; Humans; Lithium; Neuroleptic | 1990 |
Survival of severe neuroleptic malignant syndrome in a 78-year-old man treated with dantrolene.
Topics: Aged; Dantrolene; Humans; Male; Neuroleptic Malignant Syndrome | 1990 |
[Neuroleptic malignant syndrome--life-threatening but treatable].
Topics: Adult; Bromocriptine; Dantrolene; Diagnosis, Differential; Humans; Male; Neuroleptic Malignant Syndr | 1990 |
Dantrolene sodium in neuroleptic malignant syndrome and hepatic impairment.
Topics: Adult; Dantrolene; Humans; Liver Cirrhosis, Alcoholic; Liver Function Tests; Male; Neuroleptic Malig | 1990 |
Treatment of lethal catatonia with electroconvulsive therapy and dantrolene sodium: a case report.
Topics: Adolescent; Catatonia; Combined Modality Therapy; Dantrolene; Diazepam; Electroconvulsive Therapy; H | 1990 |
[Malignant neuroleptic syndrome and malignant hyperthermia--a comparison].
Topics: Adult; Amantadine; Bromocriptine; Calcium; Cross-Sectional Studies; Dantrolene; Female; Humans; Ion | 1986 |
[The neuroleptic malignant syndrome].
Topics: Aged; Dantrolene; Emergencies; Female; Humans; Neuroleptic Malignant Syndrome | 1989 |
Dysfunction in myoplasmic Ca(2+) homeostasis in neuroleptic malignant syndrome.
Topics: Calcium; Dantrolene; Homeostasis; Humans; Muscles; Neuroleptic Malignant Syndrome; Verapamil | 1989 |
Fatal thermal injury.
Topics: Dantrolene; Heat Exhaustion; Humans; Malignant Hyperthermia; Neuroleptic Malignant Syndrome | 1989 |
Neuroleptic catatonia and its relationship to psychogenic catatonia.
Topics: Anti-Anxiety Agents; Antipsychotic Agents; Basal Ganglia Diseases; Benzodiazepines; Brain; Catatonia | 1985 |
Diagnosing and treating neuroleptic malignant syndrome.
Topics: Antipsychotic Agents; Bromocriptine; Creatine Kinase; Dantrolene; Humans; Muscle Rigidity; Neurolept | 1986 |
Rigidity and fever in two psychotic patients.
Topics: Adult; Antipsychotic Agents; Bromocriptine; Dantrolene; Fever; Humans; Male; Muscle Rigidity; Neurol | 1986 |
[Neuroleptic malignant syndrome (dopamine-dependent malignant hyperthermia). 4 different cases].
Topics: Adult; Aged; Antipsychotic Agents; Brain; Bromocriptine; Dantrolene; Humans; Male; Middle Aged; Neur | 1988 |
Neuroleptic malignant syndrome: guidelines for treatment and reinstitution of neuroleptics.
Topics: Antipsychotic Agents; Bromocriptine; Dantrolene; Diagnosis, Differential; Humans; Neuroleptic Malign | 1988 |
[Neuroleptic malignant syndrome. Clinical and therapeutic considerations].
Topics: Adult; Dantrolene; Diagnosis, Differential; Female; Humans; Male; Middle Aged; Neuroleptic Malignant | 1988 |
Diagnosis and treatment of neuroleptic malignant syndrome.
Topics: Adolescent; Amantadine; Animals; Bromocriptine; Dantrolene; Electroconvulsive Therapy; Female; Human | 1988 |
[Etiologic mechanism of neuroleptic malignant syndrome--hypothesis of dopamine-serotonin imbalance].
Topics: Adult; Aged; Animals; Body Temperature Regulation; Calcium; Dantrolene; Dopamine; Female; Humans; In | 1988 |
Emergency treatment of the neuroleptic malignant syndrome.
Topics: Adult; Bromocriptine; Clinical Protocols; Dantrolene; Emergencies; Humans; Male; Neuroleptic Maligna | 1988 |
Postoperative neuroleptic malignant syndrome. A case report.
Topics: Adult; Cryotherapy; Dantrolene; Droperidol; Humans; Male; Neuroleptic Malignant Syndrome; Postoperat | 1987 |
Therapy of neuroleptic malignant syndrome.
Topics: Amantadine; Bromocriptine; Carbidopa; Combined Modality Therapy; Dantrolene; Diazepam; Dose-Response | 1986 |
Dantrolene sodium as a possible prophylactic agent against N.M.S.
Topics: Adult; Dantrolene; Fluphenazine; Humans; Male; Neuroleptic Malignant Syndrome; Recurrence; Schizophr | 1986 |
Possible central effect of dantrolene sodium in neuroleptic malignant syndrome.
Topics: Brain; Dantrolene; Female; Haloperidol; Humans; Middle Aged; Neuroleptic Malignant Syndrome; Psychot | 1986 |
Resolution of neuroleptic malignant syndrome with dantrolene sodium: case report.
Topics: Basal Ganglia Diseases; Bipolar Disorder; Dantrolene; Drug Therapy, Combination; Haloperidol; Humans | 1985 |
Dopamine agonists and neuroleptic malignant syndrome.
Topics: Alzheimer Disease; Amantadine; Basal Ganglia Diseases; Bromocriptine; Dantrolene; Humans; Male; Midd | 1985 |
[Dantrolene in the treatment of life-threatening psychiatric disease pictures. A contribution to the therapy of the malignant neuroleptic syndrome and acute febrile catatonia].
Topics: Adult; Basal Ganglia Diseases; Dantrolene; Diagnosis, Differential; Fever; Humans; Male; Malignant H | 1985 |
Neuroleptic malignant syndrome.
Topics: Adult; Basal Ganglia Diseases; Bromocriptine; Dantrolene; Diagnosis, Differential; Haloperidol; Heat | 1985 |
[Electroconvulsive and dantrolene treatment of acute febrile catatonia. A case report].
Topics: Adult; Combined Modality Therapy; Dantrolene; Electroconvulsive Therapy; Fever; Humans; Male; Malign | 1985 |